Eliyahou Et Al Harari bought $495K of CapsoVision (CV)
Executed Jul 8, disclosed Jul 11, 2 days later.
Over the 21 trading sessions from the disclosed entry session (Jul 10), the stock returned +22.2% (delay-adjusted); from the execution session (Jul 8), +15.5%. Derived: entry at the session's open, exit at the close 20 sessions later.
Eliyahou Et Al Harari (10% owner) filed 3 Form 4 reports in the trailing twelve months (3 purchases, 0 sales, 1 filed past the two-business-day deadline), most often in CapsoVision, Inc. (CV). Across 3 priced purchase filings, the average 21-session return was +2.0% from execution and +4.8% from disclosure (delay-adjusted; derived). The largest single filing was $495K of CV (81,300 sh × $6.09, as filed), executed Jul 8.
Healthcare · CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of t…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→61,068 sh × $6.73
Exec Jul 17
Filed Jul 21 · 7:04 PM ET CVPURCHASE CapsoVision, Inc. $102K
13,850 sh × $7.35
Exec Jun 26
Filed Jul 7 · 10:03 PM ET †